PO-1166 Treatment patterns and efficacy of durvalumab maintenance after CRT in real-world NSCLC patients

Autor:	Chukwuka Eze, T. Duell, A. Tufman, N. Reinmuth, Claus Belka, Julian Guggenberger, Farkhad Manapov, Benedikt Flörsch, Julian Taugner, Lukas Käsmann
Rok vydání:	2021
Předmět:	Oncology medicine.medical_specialty Durvalumab business.industry Internal medicine Medicine Radiology Nuclear Medicine and imaging Hematology business
Zdroj:	Radiotherapy and Oncology. 161:S968
ISSN:	0167-8140
DOI:	10.1016/s0167-8140(21)07617-9
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::494b77d5989720e90b3ef3b7fc4dc1d1 https://doi.org/10.1016/s0167-8140(21)07617-9 Zobrazit plný text záznamu Full Text from ScienceDirect